Global Dengue Treatment Market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
• 1.3 OVERVIEW OF THE GLOBAL DENGUE TREATMENT MARKET
• 1.4 CURRENCY AND PRICING
• 1.5 LIMITATIONS
• 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

• 2.1 MARKETS COVERED
• 2.2 GEOGRAPHICAL SCOPE
• 2.3 YEARS CONSIDERED FOR THE STUDY
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
• 2.6 MULTIVARIATE MODELLING
• 2.7 MARKET APPLICATION COVERAGE GRID
• 2.8 PRODUCT LIFELINE CURVE
• 2.9 DBMR MARKET POSITION GRID
• 2.10 VENDOR SHARE ANALYSIS
• 2.11 SECONDARY SOURCES
• 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PESTEL ANALYSIS
• 4.2 PORTER'S FIVE FORCES

5 GLOBAL DENGUE TREATMENT MARKET: REGULATIONS

• 5.1 U.S. REGULATORY SCENARIO FOR DENGUE TREATMENT
• 5.2 EUROPE REGULATORY SCENARIO FOR DENGUE TREATMENT
• 5.3 DEVELOPING COUNTRIES REGULATORY FRAMEWORK
• 5.4 LEGISLATION FOR CONTROL OF DENGUE IN SINGAPORE
• 5.5 DVCRN DEVELOPING VACCINE REGULATORS NETWORK

6 MARKET OVERVIEW

• 6.1 DRIVERS
  • 6.1.1 RISING DENGUE INCIDENCE RATE RESULT IN THE DEMAND FOR EFFECTIVE TREATMENT
  • 6.1.2 RISING WAVE OF DENGUE VACCINE LAUNCHES
  • 6.1.3 GOVERNMENT INITIATIVES AND VACCINATION PROGRAMS
  • 6.1.4 GROWTH OF MEDICAL INSURANCE IN EMERGING COUNTRIES
• 6.2 RESTRAINTS
  • 6.2.1 DELAY IN THE APPROVAL PROCESS OF VACCINES
  • 6.2.2 LACK OF AWARENESS AND HEALTHCARE INFRASTRUCTURE FOR TREATMENT OF DENGUE
  • 6.2.3 DIFFICULTY IN THE DETECTION ASSAY FOR DENGUE
• 6.3 OPPORTUNITIES
  • 6.3.1 STRATEGIC COLLABORATION WITHIN THE PHARMACEUTICAL INDUSTRY FUELS THE MARKET
  • 6.3.2 GROWING NUMBER OF PIPELINE VACCINES FOR DENGUE TREATMENT
  • 6.3.3 RISING R&D INVESTMENT AND ACTIVITIES
• 6.4 CHALLENGES
  • 6.4.1 HEALTHCARE SERVICES ARE LIMITEDLY ACCESSIBLE IN RURAL AREAS
  • 6.4.2 HIGH COSTS OF TREATMENT RESTRICT THE FEASIBILITY OF COST-EFFECTIVE SOLUTIONS

7 GLOBAL DENGUE TREATMENT MARKET, BY STRAINS

• 7.1 OVERVIEW
• 7.2 DENV-2
• 7.3 DENV-3
• 7.4 DENV-1
• 7.5 DENV-4
• 7.6 OTHERS

8 GLOBAL DENGUE TREATMENT MARKET, BY TYPE

• 8.1 OVERVIEW
• 8.2 VACCINES
  • 8.2.1 DENGVAXIA (CYD-TDV)
  • 8.2.2 QDENGA
• 8.3 ACETAMINOPHEN
  • 8.3.1 PARENTERAL
  • 8.3.2 ORAL
  • 8.3.3 OTHER

9 GLOBAL DENGUE TREATMENT MARKET, BY SEVERITY

• 9.1 OVERVIEW
• 9.2 MILD TO MODERATE DENGUE
• 9.3 SEVERE DENGUE

10 GLOBAL DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

• 10.1 OVERVIEW
• 10.2 PARENTERAL
  • 10.2.1 SUB-CUTANEOUS
  • 10.2.2 INTRAVENOUS
• 10.3 ORAL
  • 10.3.1 TABLET
  • 10.3.2 CAPSULES
  • 10.3.3 OTHERS

11 GLOBAL DENGUE TREATMENT MARKET, BY MODE OF PURCHASE

• 11.1 OVERVIEW
• 11.2 PRESCRIPTION
• 11.3 OVER-THE-COUNTER (OTC)

12 GLOBAL DENGUE TREATMENT MARKET, BY GENDER

• 12.1 OVERVIEW
• 12.2 MALE
• 12.3 FEMALE

13 GLOBAL DENGUE TREATMENT MARKET, BY AGE

• 13.1 OVERVIEW
• 13.2 ADULT
• 13.3 PEDIATRIC
• 13.4 GERIATRIC

14 GLOBAL DENGUE TREATMENT MARKET, BY END USER

• 14.1 OVERVIEW
• 14.2 HOSPITAL
• 14.3 SPECIALTY CLINICS
• 14.4 HOME HEALTHCARE
• 14.5 OTHERS

15 GLOBAL DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL

• 15.1 OVERVIEW
• 15.2 RETAIL PHARMACIES
• 15.3 HOSPITAL PHARMACIES
• 15.4 ONLINE PHARMACIES

16 GLOBAL DENGUE TREATMENT MARKET, BY REGION

• 16.1 OVERVIEW
• 16.2 ASIA-PACIFIC
  • 16.2.1 INDIA
  • 16.2.2 CHINA
  • 16.2.3 JAPAN
  • 16.2.4 INDONESIA
  • 16.2.5 MALAYSIA
  • 16.2.6 THAILAND
  • 16.2.7 AUSTRALIA
  • 16.2.8 SOUTH KOREA
  • 16.2.9 SINGAPORE
  • 16.2.10 PHILIPPINES
  • 16.2.11 REST OF ASIA-PACIFIC
• 16.3 SOUTH AMERICA
  • 16.3.1 BRAZIL
  • 16.3.2 ARGENTINA
  • 16.3.3 REST OF SOUTH AMERICA
• 16.4 NORTH AMERICA
  • 16.4.1 MEXICO
  • 16.4.2 U.S.
  • 16.4.3 CANADA
• 16.5 EUROPE
  • 16.5.1 FRANCE
  • 16.5.2 GERMANY
  • 16.5.3 SPAIN
  • 16.5.4 U.K.
  • 16.5.5 BELGIUM
  • 16.5.6 ITALY
  • 16.5.7 NETHERLANDS
  • 16.5.8 RUSSIA
  • 16.5.9 SWITZERLAND
  • 16.5.10 TURKEY
  • 16.5.11 REST OF EUROPE
• 16.6 MIDDLE EAST AND AFRICA
  • 16.6.1 EGYPT
  • 16.6.2 SAUDI ARABIA
  • 16.6.3 SOUTH AFRICA
  • 16.6.4 U.A.E
  • 16.6.5 ISRAEL
  • 16.6.6 REST OF MIDDLE EAST AND AFRICA

17 GLOBAL DENGUE TREATMENT MARKET: COMPANY LANDSCAPE

• 17.1 COMPANY SHARE ANALYSIS: GLOBAL
• 17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
• 17.3 COMPANY SHARE ANALYSIS: EUROPE
• 17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
• 17.5 COMPANY SHARE ANALYSIS: SOUTH AMERICA

18 SWOT ANALYSIS

19 COMPANY PROFILE

• 19.1 SANOFI
  • 19.1.1 COMPANY SNAPSHOT
  • 19.1.2 REVENUE ANALYSIS
  • 19.1.3 COMPANY SHARE ANALYSIS
  • 19.1.4 PRODUCT PORTFOLIO
  • 19.1.5 RECENT DEVELOPMENTS
• 19.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • 19.2.1 COMPANY SNAPSHOT
  • 19.2.2 REVENUE ANALYSIS
  • 19.2.3 COMPANY SHARE ANALYSIS
  • 19.2.4 PRODUCT PORTFOLIO
  • 19.2.5 RECENT DEVELOPMENTS
• 19.3 VIATRIS INC.
  • 19.3.1 COMPANY SNAPSHOT
  • 19.3.2 REVENUE ANALYSIS
  • 19.3.3 COMPANY SHARE ANALYSIS
  • 19.3.4 PRODUCT PORTFOLIO
  • 19.3.5 RECENT DEVELOPMENTS
• 19.4 JOHNSON & JOHNSON SERVICES, INC.
  • 19.4.1 COMPANY SNAPSHOT
  • 19.4.2 REVENUE ANALYSIS
  • 19.4.3 COMPANY SHARE ANALYSIS
  • 19.4.4 PRODUCT PORTFOLIO
  • 19.4.5 RECENT DEVELOPMENT
• 19.5 GSK PLC.
  • 19.5.1 COMPANY SNAPSHOT
  • 19.5.2 REVENUE ANALYSIS
  • 19.5.3 COMPANY SHARE ANALYSIS
  • 19.5.4 PRODUCT PORTFOLIO
  • 19.5.5 RECENT DEVELOPMENTS
• 19.6 AUROBINDO PHARMA
  • 19.6.1 COMPANY SNAPSHOT
  • 19.6.2 REVENUE ANALYSIS
  • 19.6.3 PRODUCT PORTFOLIO
• 19.7 BAXTER
  • 19.7.1 COMPANY SNAPSHOT
  • 19.7.2 REVENUE ANALYSIS
  • 19.7.3 PRODUCT PORTFOLIO
• 19.8 FRESENIUS KABI USA
  • 19.8.1 COMPANY SNAPSHOT
  • 19.8.2 PRODUCT PORTFOLIO
  • 19.8.3 RECENT DEVELOPMENTS
• 19.9 HIKMA PHARMACEUTICALS
  • 19.9.1 COMPANY SNAPSHOT
  • 19.9.2 REVENUE ANALYSIS
  • 19.9.3 PRODUCT PORTFOLIO
  • 19.9.4 RECENT DEVELOPMENT
• 19.10 PERRIGO COMPANY PLC
  • 19.10.1 COMPANY SNAPSHOT
  • 19.10.2 REVENUE ANALYSIS
  • 19.10.3 PRODUCT PORTFOLIO
  • 19.10.4 RECENT DEVELOPMENT
• 19.11 PFIZER INC.
  • 19.11.1 COMPANY SNAPSHOT
  • 19.11.2 REVENUE ANALYSIS
  • 19.11.3 PRODUCT PORTFOLIO
  • 19.11.4 RECENT DEVELOPMENTS
• 19.12 SUN PHARMACEUTICAL INDUSTRIES LTD
  • 19.12.1 COMPANY SNAPSHOT
  • 19.12.2 REVENUE ANALYSIS
  • 19.12.3 PRODUCT PORTFOLIO
  • 19.12.4 RECENT DEVELOPMENT
• 19.13 TEVA PHARMACEUTICALS USA, INC.
  • 19.13.1 COMPANY SNAPSHOT
  • 19.13.2 REVENUE ANALYSIS
  • 19.13.3 PRODUCT PORTFOLIO
  • 19.13.4 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORTS

LIST OF TABLES

• TABLE 1 THREE PHASES FOR HEALTH PROTECTION OUTLINED BY THE EUROPEAN WORLD HEALTH ORGANIZATION
• TABLE 2 IMPACT OF DELAY IN APPROVAL PROCESS
• TABLE 3 GLOBAL DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 4 GLOBAL DENV-2 IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 5 GLOBAL DENV-3 IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 6 GLOBAL DENV-1 IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 7 GLOBAL DENV-4 IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 8 GLOBAL OTHERS IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 9 GLOBAL DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 10 GLOBAL VACCINES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 11 GLOBAL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 12 GLOBAL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 13 GLOBAL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 14 GLOBAL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 15 GLOBAL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 16 GLOBAL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 17 GLOBAL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 18 GLOBAL DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 19 GLOBAL MILD TO MODERATE DENGUE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 20 GLOBAL SEVERE DENGUE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 21 GLOBAL DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 22 GLOBAL PARENTERAL IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 23 GLOBAL PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 24 GLOBAL ORAL IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 25 GLOBAL ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 26 GLOBAL DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 27 GLOBAL PRESCRIPTION IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 28 GLOBAL OVER-THE-COUNTER (OTC) IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 29 GLOBAL DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 30 GLOBAL MALE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 31 GLOBAL FEMALE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 32 GLOBAL DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 33 GLOBAL ADULT IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 34 GLOBAL PEDIATRIC IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 35 GLOBAL GERIATRIC IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 36 GLOBAL DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 37 GLOBAL HOSPITAL IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 38 GLOBAL SPECIALITY CLINICS IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 39 GLOBAL HOME HEALTHCARE IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 40 GLOBAL OTHERS IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 41 GLOBAL DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 42 GLOBAL RETAIL PHARMACIES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 43 GLOBAL HOSPITAL PHARMACIES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 44 GLOBAL ONLINE PHARMACIES IN DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 45 GLOBAL DENGUE TREATMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
• TABLE 46 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
• TABLE 47 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 48 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 49 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 50 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 51 ASIA-PACIFIC VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 52 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 53 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 54 ASIA-PACIFIC ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 55 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 56 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 57 ASIA-PACIFIC PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 58 ASIA-PACIFIC ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 59 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 60 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 61 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 62 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 63 ASIA-PACIFIC DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 64 INDIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 65 INDIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 66 INDIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 67 INDIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 68 INDIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 69 INDIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 70 INDIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 71 INDIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 72 INDIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 73 INDIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 74 INDIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 75 INDIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 76 INDIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 77 INDIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 78 INDIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 79 INDIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 80 INDIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 81 CHINA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 82 CHINA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 83 CHINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 84 CHINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 85 CHINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 86 CHINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 87 CHINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 88 CHINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 89 CHINA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 90 CHINA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 91 CHINA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 92 CHINA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 93 CHINA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 94 CHINA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 95 CHINA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 96 CHINA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 97 CHINA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 98 JAPAN DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 99 JAPAN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 100 JAPAN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 101 JAPAN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 102 JAPAN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 103 JAPAN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 104 JAPAN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 105 JAPAN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 106 JAPAN DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 107 JAPAN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 108 JAPAN PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 109 JAPAN ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 110 JAPAN DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 111 JAPAN DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 112 JAPAN DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 113 JAPAN DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 114 JAPAN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 115 INDONESIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 116 INDONESIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 117 INDONESIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 118 INDONESIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 119 INDONESIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 120 INDONESIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 121 INDONESIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 122 INDONESIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 123 INDONESIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 124 INDONESIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 125 INDONESIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 126 INDONESIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 127 INDONESIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 128 INDONESIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 129 INDONESIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 130 INDONESIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 131 INDONESIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 132 MALAYSIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 133 MALAYSIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 134 MALAYSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 135 MALAYSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 136 MALAYSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 137 MALAYSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 138 MALAYSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 139 MALAYSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 140 MALAYSIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 141 MALAYSIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 142 MALAYSIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 143 MALAYSIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 144 MALAYSIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 145 MALAYSIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 146 MALAYSIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 147 MALAYSIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 148 MALAYSIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 149 THAILAND DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 150 THAILAND DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 151 THAILAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 152 THAILAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 153 THAILAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 154 THAILAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 155 THAILAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 156 THAILAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 157 THAILAND DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 158 THAILAND DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 159 THAILAND PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 160 THAILAND ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 161 THAILAND DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 162 THAILAND DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 163 THAILAND DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 164 THAILAND DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 165 THAILAND DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 166 AUSTRALIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 167 AUSTRALIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 168 AUSTRALIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 169 AUSTRALIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 170 AUSTRALIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 171 AUSTRALIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 172 AUSTRALIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 173 AUSTRALIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 174 AUSTRALIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 175 AUSTRALIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 176 AUSTRALIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 177 AUSTRALIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 178 AUSTRALIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 179 AUSTRALIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 180 AUSTRALIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 181 AUSTRALIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 182 AUSTRALIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 183 SOUTH KOREA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 184 SOUTH KOREA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 185 SOUTH KOREA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 186 SOUTH KOREA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 187 SOUTH KOREA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 188 SOUTH KOREA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 189 SOUTH KOREA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 190 SOUTH KOREA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 191 SOUTH KOREA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 192 SOUTH KOREA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 193 SOUTH KOREA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 194 SOUTH KOREA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 195 SOUTH KOREA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 196 SOUTH KOREA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 197 SOUTH KOREA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 198 SOUTH KOREA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 199 SOUTH KOREA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 200 SINGAPORE DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 201 SINGAPORE DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 202 SINGAPORE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 203 SINGAPORE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 204 SINGAPORE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 205 SINGAPORE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 206 SINGAPORE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 207 SINGAPORE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 208 SINGAPORE DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 209 SINGAPORE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 210 SINGAPORE PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 211 SINGAPORE ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 212 SINGAPORE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 213 SINGAPORE DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 214 SINGAPORE DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 215 SINGAPORE DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 216 SINGAPORE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 217 PHILIPPINES DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 218 PHILIPPINES DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 219 PHILIPPINES VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 220 PHILIPPINES VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 221 PHILIPPINES VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 222 PHILIPPINES ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 223 PHILIPPINES ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 224 PHILIPPINES ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 225 PHILIPPINES DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION)
• TABLE 226 PHILIPPINES DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)
• TABLE 227 PHILIPPINES PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 228 PHILIPPINES ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 229 PHILIPPINES DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
• TABLE 230 PHILIPPINES DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION)
• TABLE 231 PHILIPPINES DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION)
• TABLE 232 PHILIPPINES DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
• TABLE 233 PHILIPPINES DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
• TABLE 234 REST OF ASIA-PACIFIC DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 235 SOUTH AMERICA DENGUE TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
• TABLE 236 SOUTH AMERICA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION)
• TABLE 237 SOUTH AMERICA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 238 SOUTH AMERICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION)
• TABLE 239 SOUTH AMERICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME)
• TABLE 240 SOUTH AMERICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP)
• TABLE 241 SOUTH AMERICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 200
• TABLE 242 SOUTH AMERICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 201
• TABLE 243 SOUTH AMERICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 201
• TABLE 244 SOUTH AMERICA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 201
• TABLE 245 SOUTH AMERICA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 201
• TABLE 246 SOUTH AMERICA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 202
• TABLE 247 SOUTH AMERICA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 202
• TABLE 248 SOUTH AMERICA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 202
• TABLE 249 SOUTH AMERICA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 202
• TABLE 250 SOUTH AMERICA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 203
• TABLE 251 SOUTH AMERICA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 203
• TABLE 252 SOUTH AMERICA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 203
• TABLE 253 BRAZIL DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 204
• TABLE 254 BRAZIL DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 204
• TABLE 255 BRAZIL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 204
• TABLE 256 BRAZIL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 204
• TABLE 257 BRAZIL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 205
• TABLE 258 BRAZIL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 205
• TABLE 259 BRAZIL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 205
• TABLE 260 BRAZIL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 205
• TABLE 261 BRAZIL DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 206
• TABLE 262 BRAZIL DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 206
• TABLE 263 BRAZIL PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 206
• TABLE 264 BRAZIL ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 206
• TABLE 265 BRAZIL DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 207
• TABLE 266 BRAZIL DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 207
• TABLE 267 BRAZIL DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 207
• TABLE 268 BRAZIL DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 207
• TABLE 269 BRAZIL DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 208
• TABLE 270 ARGENTINA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 209
• TABLE 271 ARGENTINA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 209
• TABLE 272 ARGENTINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 209
• TABLE 273 ARGENTINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 209
• TABLE 274 ARGENTINA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 210
• TABLE 275 ARGENTINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 210
• TABLE 276 ARGENTINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 210
• TABLE 277 ARGENTINA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 210
• TABLE 278 ARGENTINA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 211
• TABLE 279 ARGENTINA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 211
• TABLE 280 ARGENTINA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 211
• TABLE 281 ARGENTINA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 211
• TABLE 282 ARGENTINA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 212
• TABLE 283 ARGENTINA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 212
• TABLE 284 ARGENTINA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 212
• TABLE 285 ARGENTINA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 212
• TABLE 286 ARGENTINA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 213
• TABLE 287 REST OF SOUTH AMERICA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 214
• TABLE 288 NORTH AMERICA DENGUE TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION) 215
• TABLE 289 NORTH AMERICA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 215
• TABLE 290 NORTH AMERICA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 215
• TABLE 291 NORTH AMERICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 216
• TABLE 292 NORTH AMERICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 216
• TABLE 293 NORTH AMERICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 216
• TABLE 294 NORTH AMERICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 216
• TABLE 295 NORTH AMERICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 217
• TABLE 296 NORTH AMERICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 217
• TABLE 297 NORTH AMERICA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 217
• TABLE 298 NORTH AMERICA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 217
• TABLE 299 NORTH AMERICA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 218
• TABLE 300 NORTH AMERICA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 218
• TABLE 301 NORTH AMERICA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 218
• TABLE 302 NORTH AMERICA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 218
• TABLE 303 NORTH AMERICA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 219
• TABLE 304 NORTH AMERICA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 219
• TABLE 305 NORTH AMERICA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 219
• TABLE 306 MEXICO DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 220
• TABLE 307 MEXICO DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 220
• TABLE 308 MEXICO VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 220
• TABLE 309 MEXICO VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 220
• TABLE 310 MEXICO VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 221
• TABLE 311 MEXICO ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 221
• TABLE 312 MEXICO ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 221
• TABLE 313 MEXICO ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 221
• TABLE 314 MEXICO DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 222
• TABLE 315 MEXICO DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 222
• TABLE 316 MEXICO PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 222
• TABLE 317 MEXICO ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 222
• TABLE 318 MEXICO DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 223
• TABLE 319 MEXICO DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 223
• TABLE 320 MEXICO DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 223
• TABLE 321 MEXICO DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 223
• TABLE 322 MEXICO DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 224
• TABLE 323 U.S. DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 225
• TABLE 324 U.S. DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 225
• TABLE 325 U.S. VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 225
• TABLE 326 U.S. VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 225
• TABLE 327 U.S. VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 226
• TABLE 328 U.S. ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 226
• TABLE 329 U.S. ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 226
• TABLE 330 U.S. ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 226
• TABLE 331 U.S. DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 227
• TABLE 332 U.S. DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 227
• TABLE 333 U.S. PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 227
• TABLE 334 U.S. ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 227
• TABLE 335 U.S. DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 228
• TABLE 336 U.S. DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 228
• TABLE 337 U.S. DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 228
• TABLE 338 U.S. DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 228
• TABLE 339 U.S. DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 229
• TABLE 340 CANADA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 230
• TABLE 341 CANADA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 230
• TABLE 342 CANADA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 230
• TABLE 343 CANADA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 230
• TABLE 344 CANADA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 231
• TABLE 345 CANADA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 231
• TABLE 346 CANADA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 231
• TABLE 347 CANADA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 231
• TABLE 348 CANADA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 232
• TABLE 349 CANADA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 232
• TABLE 350 CANADA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 232
• TABLE 351 CANADA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 232
• TABLE 352 CANADA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 233
• TABLE 353 CANADA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 233
• TABLE 354 CANADA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 233
• TABLE 355 CANADA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 233
• TABLE 356 CANADA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 234
• TABLE 357 EUROPE DENGUE TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION) 235
• TABLE 358 EUROPE DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 236
• TABLE 359 EUROPE DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 236
• TABLE 360 EUROPE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 236
• TABLE 361 EUROPE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 236
• TABLE 362 EUROPE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 237
• TABLE 363 EUROPE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 237
• TABLE 364 EUROPE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 237
• TABLE 365 EUROPE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 237
• TABLE 366 EUROPE DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 238
• TABLE 367 EUROPE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 238
• TABLE 368 EUROPE PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 238
• TABLE 369 EUROPE ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 238
• TABLE 370 EUROPE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 239
• TABLE 371 EUROPE DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 239
• TABLE 372 EUROPE DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 239
• TABLE 373 EUROPE DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 239
• TABLE 374 EUROPE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 240
• TABLE 375 FRANCE DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 241
• TABLE 376 FRANCE DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 241
• TABLE 377 FRANCE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 241
• TABLE 378 FRANCE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 242
• TABLE 379 FRANCE VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 242
• TABLE 380 FRANCE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 242
• TABLE 381 FRANCE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 242
• TABLE 382 FRANCE ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 243
• TABLE 383 FRANCE DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 243
• TABLE 384 FRANCE DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 243
• TABLE 385 FRANCE PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 243
• TABLE 386 FRANCE ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 244
• TABLE 387 FRANCE DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 244
• TABLE 388 FRANCE DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 244
• TABLE 389 FRANCE DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 244
• TABLE 390 FRANCE DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 245
• TABLE 391 FRANCE DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 245
• TABLE 392 GERMANY DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 246
• TABLE 393 GERMANY DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 246
• TABLE 394 GERMANY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 246
• TABLE 395 GERMANY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 246
• TABLE 396 GERMANY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 247
• TABLE 397 GERMANY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 247
• TABLE 398 GERMANY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 247
• TABLE 399 GERMANY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 247
• TABLE 400 GERMANY DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 248
• TABLE 401 GERMANY DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 248
• TABLE 402 GERMANY PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 248
• TABLE 403 GERMANY ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 248
• TABLE 404 GERMANY DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 249
• TABLE 405 GERMANY DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 249
• TABLE 406 GERMANY DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 249
• TABLE 407 GERMANY DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 249
• TABLE 408 GERMANY DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 250
• TABLE 409 SPAIN DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 251
• TABLE 410 SPAIN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 251
• TABLE 411 SPAIN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 251
• TABLE 412 SPAIN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 252
• TABLE 413 SPAIN VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 252
• TABLE 414 SPAIN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 252
• TABLE 415 SPAIN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 252
• TABLE 416 SPAIN ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 253
• TABLE 417 SPAIN DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 253
• TABLE 418 SPAIN DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 253
• TABLE 419 SPAIN PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 253
• TABLE 420 SPAIN ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 254
• TABLE 421 SPAIN DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 254
• TABLE 422 SPAIN DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 254
• TABLE 423 SPAIN DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 254
• TABLE 424 SPAIN DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 255
• TABLE 425 SPAIN DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 255
• TABLE 426 U.K. DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 256
• TABLE 427 U.K. DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 256
• TABLE 428 U.K. VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 256
• TABLE 429 U.K. VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 256
• TABLE 430 U.K. VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 257
• TABLE 431 U.K. ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 257
• TABLE 432 U.K. ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 257
• TABLE 433 U.K. ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 257
• TABLE 434 U.K. DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 257
• TABLE 435 U.K. DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 258
• TABLE 436 U.K. PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 258
• TABLE 437 U.K. ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 258
• TABLE 438 U.K. DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 258
• TABLE 439 U.K. DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 259
• TABLE 440 U.K. DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 259
• TABLE 441 U.K. DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 259
• TABLE 442 U.K. DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 260
• TABLE 443 BELGIUM DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 261
• TABLE 444 BELGIUM DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 261
• TABLE 445 BELGIUM VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 261
• TABLE 446 BELGIUM VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 261
• TABLE 447 BELGIUM VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 262
• TABLE 448 BELGIUM ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 262
• TABLE 449 BELGIUM ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 262
• TABLE 450 BELGIUM ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 262
• TABLE 451 BELGIUM DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 263
• TABLE 452 BELGIUM DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 263
• TABLE 453 BELGIUM PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 263
• TABLE 454 BELGIUM ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 263
• TABLE 455 BELGIUM DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 264
• TABLE 456 BELGIUM DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 264
• TABLE 457 BELGIUM DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 264
• TABLE 458 BELGIUM DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 264
• TABLE 459 BELGIUM DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 265
• TABLE 460 ITALY DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 266
• TABLE 461 ITALY DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 266
• TABLE 462 ITALY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 266
• TABLE 463 ITALY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 266
• TABLE 464 ITALY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 267
• TABLE 465 ITALY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 267
• TABLE 466 ITALY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 267
• TABLE 467 ITALY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 267
• TABLE 468 ITALY DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 267
• TABLE 469 ITALY DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 268
• TABLE 470 ITALY PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 268
• TABLE 471 ITALY ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 268
• TABLE 472 ITALY DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 268
• TABLE 473 ITALY DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 269
• TABLE 474 ITALY DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 269
• TABLE 475 ITALY DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 269
• TABLE 476 ITALY DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 270
• TABLE 477 NETHERLANDS DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 271
• TABLE 478 NETHERLANDS DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 271
• TABLE 479 NETHERLANDS VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 271
• TABLE 480 NETHERLANDS VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 271
• TABLE 481 NETHERLANDS VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 272
• TABLE 482 NETHERLANDS ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 272
• TABLE 483 NETHERLANDS ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 272
• TABLE 484 NETHERLANDS ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 272
• TABLE 485 NETHERLANDS DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 273
• TABLE 486 NETHERLANDS DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 273
• TABLE 487 NETHERLANDS PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 273
• TABLE 488 NETHERLANDS ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 273
• TABLE 489 NETHERLANDS DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 274
• TABLE 490 NETHERLANDS DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 274
• TABLE 491 NETHERLANDS DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 274
• TABLE 492 NETHERLANDS DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 275
• TABLE 493 NETHERLANDS DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 275
• TABLE 494 RUSSIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 276
• TABLE 495 RUSSIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 276
• TABLE 496 RUSSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 276
• TABLE 497 RUSSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 276
• TABLE 498 RUSSIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 277
• TABLE 499 RUSSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 277
• TABLE 500 RUSSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 277
• TABLE 501 RUSSIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 277
• TABLE 502 RUSSIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 278
• TABLE 503 RUSSIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 278
• TABLE 504 RUSSIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 278
• TABLE 505 RUSSIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 278
• TABLE 506 RUSSIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 279
• TABLE 507 RUSSIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 279
• TABLE 508 RUSSIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 279
• TABLE 509 RUSSIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 279
• TABLE 510 RUSSIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 280
• TABLE 511 SWITZERLAND DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 281
• TABLE 512 SWITZERLAND DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 281
• TABLE 513 SWITZERLAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 281
• TABLE 514 SWITZERLAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 281
• TABLE 515 SWITZERLAND VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 282
• TABLE 516 SWITZERLAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 282
• TABLE 517 SWITZERLAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 282
• TABLE 518 SWITZERLAND ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 282
• TABLE 519 SWITZERLAND DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 283
• TABLE 520 SWITZERLAND DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 283
• TABLE 521 SWITZERLAND PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 283
• TABLE 522 SWITZERLAND ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 283
• TABLE 523 SWITZERLAND DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 284
• TABLE 524 SWITZERLAND DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 284
• TABLE 525 SWITZERLAND DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 284
• TABLE 526 SWITZERLAND DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 285
• TABLE 527 SWITZERLAND DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 285
• TABLE 528 TURKEY DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 286
• TABLE 529 TURKEY DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 286
• TABLE 530 TURKEY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 286
• TABLE 531 TURKEY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 286
• TABLE 532 TURKEY VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 286
• TABLE 533 TURKEY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 287
• TABLE 534 TURKEY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 287
• TABLE 535 TURKEY ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 287
• TABLE 536 TURKEY DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 287
• TABLE 537 TURKEY DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 288
• TABLE 538 TURKEY PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 288
• TABLE 539 TURKEY ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 288
• TABLE 540 TURKEY DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 288
• TABLE 541 TURKEY DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 289
• TABLE 542 TURKEY DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 289
• TABLE 543 TURKEY DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 289
• TABLE 544 TURKEY DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 289
• TABLE 545 REST OF EUROPE DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 290
• TABLE 546 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION) 291
• TABLE 547 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 291
• TABLE 548 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 292
• TABLE 549 MIDDLE EAST AND AFRICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 292
• TABLE 550 MIDDLE EAST AND AFRICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 292
• TABLE 551 MIDDLE EAST AND AFRICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 292
• TABLE 552 MIDDLE EAST AND AFRICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 293
• TABLE 553 MIDDLE EAST AND AFRICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 293
• TABLE 554 MIDDLE EAST AND AFRICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 293
• TABLE 555 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 293
• TABLE 556 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 294
• TABLE 557 MIDDLE EAST AND AFRICA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 294
• TABLE 558 MIDDLE EAST AND AFRICA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 294
• TABLE 559 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 295
• TABLE 560 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 295
• TABLE 561 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 295
• TABLE 562 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 296
• TABLE 563 MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 296
• TABLE 564 EGYPT DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 297
• TABLE 565 EGYPT DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 297
• TABLE 566 EGYPT VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 297
• TABLE 567 EGYPT VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 297
• TABLE 568 EGYPT VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 298
• TABLE 569 EGYPT ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 298
• TABLE 570 EGYPT ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 298
• TABLE 571 EGYPT ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 298
• TABLE 572 EGYPT DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 299
• TABLE 573 EGYPT DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 299
• TABLE 574 EGYPT PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 299
• TABLE 575 EGYPT ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 299
• TABLE 576 EGYPT DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 300
• TABLE 577 EGYPT DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 300
• TABLE 578 EGYPT DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 300
• TABLE 579 EGYPT DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 300
• TABLE 580 EGYPT DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 301
• TABLE 581 SAUDI ARABIA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 302
• TABLE 582 SAUDI ARABIA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 302
• TABLE 583 SAUDI ARABIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 302
• TABLE 584 SAUDI ARABIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 302
• TABLE 585 SAUDI ARABIA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 303
• TABLE 586 SAUDI ARABIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 303
• TABLE 587 SAUDI ARABIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 303
• TABLE 588 SAUDI ARABIA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 303
• TABLE 589 SAUDI ARABIA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 304
• TABLE 590 SAUDI ARABIA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 304
• TABLE 591 SAUDI ARABIA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 304
• TABLE 592 SAUDI ARABIA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 304
• TABLE 593 SAUDI ARABIA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 305
• TABLE 594 SAUDI ARABIA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 305
• TABLE 595 SAUDI ARABIA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 305
• TABLE 596 SAUDI ARABIA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 306
• TABLE 597 SAUDI ARABIA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 306
• TABLE 598 SOUTH AFRICA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 307
• TABLE 599 SOUTH AFRICA DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 307
• TABLE 600 SOUTH AFRICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 307
• TABLE 601 SOUTH AFRICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 307
• TABLE 602 SOUTH AFRICA VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 308
• TABLE 603 SOUTH AFRICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 308
• TABLE 604 SOUTH AFRICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 308
• TABLE 605 SOUTH AFRICA ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 308
• TABLE 606 SOUTH AFRICA DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 309
• TABLE 607 SOUTH AFRICA DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 309
• TABLE 608 SOUTH AFRICA PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 309
• TABLE 609 SOUTH AFRICA ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 309
• TABLE 610 SOUTH AFRICA DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 310
• TABLE 611 SOUTH AFRICA DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 310
• TABLE 612 SOUTH AFRICA DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 310
• TABLE 613 SOUTH AFRICA DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 311
• TABLE 614 SOUTH AFRICA DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 311
• TABLE 615 U.A.E DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 312
• TABLE 616 U.A.E DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 312
• TABLE 617 U.A.E VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 312
• TABLE 618 U.A.E VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 312
• TABLE 619 U.A.E VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 313
• TABLE 620 U.A.E ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 313
• TABLE 621 U.A.E ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 313
• TABLE 622 U.A.E ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 313
• TABLE 623 U.A.E DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 314
• TABLE 624 U.A.E DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 314
• TABLE 625 U.A.E PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 314
• TABLE 626 U.A.E ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 314
• TABLE 627 U.A.E DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 315
• TABLE 628 U.A.E DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 315
• TABLE 629 U.A.E DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 315
• TABLE 630 U.A.E DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 315
• TABLE 631 U.A.E DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 316
• TABLE 632 ISRAEL DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 317
• TABLE 633 ISRAEL DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 317
• TABLE 634 ISRAEL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 317
• TABLE 635 ISRAEL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 317
• TABLE 636 ISRAEL VACCINES IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 318
• TABLE 637 ISRAEL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 318
• TABLE 638 ISRAEL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (VOLUME) 318
• TABLE 639 ISRAEL ACETAMINOPHEN IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (ASP) 318
• TABLE 640 ISRAEL DENGUE TREATMENT MARKET, BY SEVERITY, 2022-2031 (USD MILLION) 319
• TABLE 641 ISRAEL DENGUE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 319
• TABLE 642 ISRAEL PARENTERAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 319
• TABLE 643 ISRAEL ORAL IN DENGUE TREATMENT MARKET, BY TYPE, 2022-2031 (USD MILLION) 319
• TABLE 644 ISRAEL DENGUE TREATMENT MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION) 320
• TABLE 645 ISRAEL DENGUE TREATMENT MARKET, BY GENDER, 2022-2031 (USD MILLION) 320
• TABLE 646 ISRAEL DENGUE TREATMENT MARKET, BY AGE, 2022-2031 (USD MILLION) 320
• TABLE 647 ISRAEL DENGUE TREATMENT MARKET, BY END USER, 2022-2031 (USD MILLION) 321
• TABLE 648 ISRAEL DENGUE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 321
• TABLE 649 REST OF MIDDLE EAST AND AFRICA DENGUE TREATMENT MARKET, BY STRAINS, 2022-2031 (USD MILLION) 322

LIST OF FIGURES

• FIGURE 1 GLOBAL DENGUE TREATMENT MARKET: SEGMENTATION
• FIGURE 2 GLOBAL DENGUE TREATMENT MARKET: DATA TRIANGULATION
• FIGURE 3 GLOBAL DENGUE TREATMENT MARKET: DROC ANALYSIS
• FIGURE 4 GLOBAL DENGUE TREATMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
• FIGURE 5 GLOBAL DENGUE TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
• FIGURE 6 GLOBAL DENGUE TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
• FIGURE 7 GLOBAL DENGUE TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID
• FIGURE 8 GLOBAL DENGUE TREATMENT MARKET: DBMR MARKET POSITION GRID
• FIGURE 9 GLOBAL DENGUE TREATMENT MARKET: VENDOR SHARE ANALYSIS
• FIGURE 10 GLOBAL DENGUE TREATMENT MARKET: SEGMENTATION
• FIGURE 11 GROWING PHARMACEUTICAL INDUSTRY IS DRIVING THE GROWTH OF THE GLOBAL DENGUE TREATMENT MARKET FROM 2024 TO 2031
• FIGURE 12 ON THE BASIS OF STRAINS, THE DENV-2 SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL DENGUE TREATMENT MARKET IN 2024 AND 2031
• FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE THE GLOBAL DENGUE TREATMENT MARKET AND EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
• FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR GLOBAL DENGUE TREATMENT MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
• FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL DENGUE TREATMENT MARKET
• FIGURE 16 FINANCIAL BUDGET FOR VECTOR-BORNE -DISEASES INCLUDING DENGUE IN INDIA
• FIGURE 17 GLOBAL DENGUE TREATMENT MARKET: BY STRAINS, 2023
• FIGURE 18 GLOBAL DENGUE TREATMENT MARKET: BY STRAINS, 2024-2031 (USD MILLION)
• FIGURE 19 GLOBAL DENGUE TREATMENT MARKET: BY STRAINS, CAGR (2024-2031)
• FIGURE 20 GLOBAL DENGUE TREATMENT MARKET: BY STRAINS, LIFELINE CURVE
• FIGURE 21 GLOBAL DENGUE TREATMENT MARKET: BY TYPE, 2023
• FIGURE 22 GLOBAL DENGUE TREATMENT MARKET: BY TYPE, 2024-2031 (USD MILLION)
• FIGURE 23 GLOBAL DENGUE TREATMENT MARKET: BY TYPE, CAGR (2024-2031)
• FIGURE 24 GLOBAL DENGUE TREATMENT MARKET: BY TYPE, LIFELINE CURVE
• FIGURE 25 GLOBAL DENGUE TREATMENT MARKET: BY SEVERITY, 2023
• FIGURE 26 GLOBAL DENGUE TREATMENT MARKET: BY SEVERITY, 2024-2031 (USD MILLION)
• FIGURE 27 GLOBAL DENGUE TREATMENT MARKET: BY SEVERITY, CAGR (2024-2031)
• FIGURE 28 GLOBAL DENGUE TREATMENT MARKET: BY SEVERITY, LIFELINE CURVE
• FIGURE 29 GLOBAL DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2023
• FIGURE 30 GLOBAL DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2024-2031 (USD MILLION)
• FIGURE 31 GLOBAL DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2024-2031)
• FIGURE 32 GLOBAL DENGUE TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
• FIGURE 33 GLOBAL DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, 2023
• FIGURE 34 GLOBAL DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
• FIGURE 35 GLOBAL DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
• FIGURE 36 GLOBAL DENGUE TREATMENT MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
• FIGURE 37 GLOBAL DENGUE TREATMENT MARKET: BY GENDER, 2023
• FIGURE 38 GLOBAL DENGUE TREATMENT MARKET: BY GENDER, 2024-2031 (USD MILLION)
• FIGURE 39 GLOBAL DENGUE TREATMENT MARKET: BY GENDER, CAGR (2024-2031)
• FIGURE 40 GLOBAL DENGUE TREATMENT MARKET: BY GENDER, LIFELINE CURVE
• FIGURE 41 GLOBAL DENGUE TREATMENT MARKET: BY AGE, 2023
• FIGURE 42 GLOBAL DENGUE TREATMENT MARKET: BY AGE, 2024-2031 (USD MILLION)
• FIGURE 43 GLOBAL DENGUE TREATMENT MARKET: BY AGE, CAGR (2024-2031)
• FIGURE 44 GLOBAL DENGUE TREATMENT MARKET: BY AGE, LIFELINE CURVE
• FIGURE 45 GLOBAL DENGUE TREATMENT MARKET: BY END USER, 2023
• FIGURE 46 GLOBAL DENGUE TREATMENT MARKET: BY END USER, 2024-2031 (USD MILLION)
• FIGURE 47 GLOBAL DENGUE TREATMENT MARKET: BY END USER, CAGR (2024-2031)
• FIGURE 48 GLOBAL DENGUE TREATMENT MARKET: BY END USER, LIFELINE CURVE
• FIGURE 49 GLOBAL DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2023
• FIGURE 50 GLOBAL DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
• FIGURE 51 GLOBAL DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
• FIGURE 52 GLOBAL DENGUE TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
• FIGURE 53 GLOBAL DENGUE TREATMENT MARKET: SNAPSHOT (2023)
• FIGURE 54 GLOBAL DENGUE TREATMENT MARKET: COMPANY SHARE 2022 (%)
• FIGURE 55 NORTH AMERICA DENGUE TREATMENT MARKET: COMPANY SHARE 2022 (%)
• FIGURE 56 EUROPE DENGUE TREATMENT MARKET: COMPANY SHARE 2022 (%)
• FIGURE 57 AISA-PACIFIC DENGUE TREATMENT MARKET: COMPANY SHARE 2022 (%)